Improving autoimmune gastritis diagnosis with PDCA model
Part of Digestive system clinical trials.
This trial tests a quality-improvement method (PDCA) to help doctors better diagnose autoimmune gastritis (AIG) during endoscopy. If it works, it could lead to more accurate diagnoses for patients with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a gastroenterologist working in the endoscopy center at Ningbo No. 1 Hospital in 2024.
- You must be willing to follow the PDCA management model throughout the study.
- You cannot withdraw from the PDCA management or stop performing gastroscopies midway.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether betaine hydrochloride, a supplement that helps with digestion, can improve symptoms in people with autoimmune gastritis. It is for adults who have been diagnosed with this condition and have high gastrin levels or a related stomach history.
This study looks at whether people with autoimmune gastritis (a stomach condition) are more likely to have small intestinal bacterial overgrowth (SIBO), which can cause bloating and other symptoms. It uses a simple breath test and questionnaires.
This trial tests if betaine hydrochloride can lower high gastrin levels caused by autoimmune gastritis. It may help people with this condition by reducing stomach-related symptoms.
This study follows patients with pre-cancerous stomach conditions to learn more about how they progress. By collecting health information over time, researchers hope to improve early detection and treatment of stomach cancer.
This trial tests whether an AI system helps endoscopy doctors better identify a stomach condition called gastric intestinal metaplasia. It is for endoscopists who already do many image-enhanced endoscopy procedures and are new to this study.
This study follows people with autoimmune atrophic gastritis to understand how the condition changes over time and what symptoms or complications may arise. It aims to collect information that could improve future care.
Hear when a new Autoimmune Gastritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.